Getting to the Heart of the Matter: An Overview of Cardiac Toxicity Related to Cancer Therapy | Zendy

Carine E. Hamo | Zendy; Michelle Bloom | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Getting to the Heart of the Matter: An Overview of Cardiac Toxicity Related to Cancer Therapy

Author(s) -

Carine E. Hamo,

Michelle Bloom

Publication year - 2015

Publication title -

clinical medicine insights cardiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.634

H-Index - 21

ISSN - 1179-5468

DOI - 10.4137/cmc.s19704

Subject(s) - cardiotoxicity , medicine , cardiac toxicity , radiation therapy , intensive care medicine , cancer , cancer therapy , cardiac dysfunction , chemotherapy , oncology , heart failure

With the improvement in cancer survival, long-term cardiotoxicity has become an area of increased interest. Various cancer therapies, including chemotherapy and radiation therapy can lead to cardiac toxicities with both acute and chronic manifestations. Awareness and early recognition can lead to improvement in cardiac survival and patient outcomes. The focus of this review is to summarize the cancer therapy agents most often associated with cardiovascular side effects, highlighting their mechanism of action and strategies for surveillance and prevention.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research